Literature DB >> 7949105

Regulation of protein kinase C (PKC) expression by iron: effect of different iron compounds on PKC-beta and PKC-alpha gene expression and role of the 5'-flanking region of the PKC-beta gene in the response to ferric transferrin.

O Alcantara1, L Obeid, Y Hannun, P Ponka, D H Boldt.   

Abstract

We have studied effects of ferric transferrin (FeTF), ferric lactoferrin (FeLF), ferric complexes of pyridoxal- or salicylaldehyde-isonicotinoyl hydrazone, (Fe-PIH, Fe-SIH), and ferric ammonium citrate (FAC) on expression of protein kinase C (PKC) mRNA transcripts in a variety of cultured cell lines. FeTF supported an increase of PKC-beta mRNA transcripts in T-lymphoblastoid (CCRF-CEM; Jurkat), B-lymphoblastoid (Daudi; Raji), promyelocyte (HL-60), erythroleukemia (K562), and monocyte (U937) cell lines. By contrast, FeLF, Fe-PIH, and Fe-SIH did not support an increase of PKC-beta mRNA transcripts in any of these cell lines. Furthermore, FAC supported an increase of PKC-beta mRNA transcripts in HL-60, K562, and U937 cells only. Preincubation of cells with desferrioxamine (DF), a cell-permeable iron chelator, abolished the increments of PKC-beta mRNA observed in response to FeTF or FAC. In contrast to results with PKC-beta, neither FeTF nor FAC caused an increase of PKC-alpha transcripts in any cell line. To locate iron-responsive DNA regulatory elements of the PKC-beta gene, we prepared genetic constructs containing various portions of the human PKC-beta 5'-flanking DNA linked to the firefly luciferase gene. Constructs were cotransfected with the neomycin resistance plasmid, Pwl-neo, into HRE H9 cells, and stable transfectants were selected in G418. Treatment with FeTF of transfectants bearing chimeric gene constructs with 2,200 bp of the PKC-beta 5'-flanking region increased luciferase activity and mRNA transcripts 2.5-fold. This increase was blocked by DF. Neither luciferase activity nor mRNA increased with FeTF in stable transfectants bearing constructs with 342 bp or 587 bp of the PKC-beta 5'-flanking region. These data provide direct confirmation that iron is involved in regulation of PKC-beta but not PKC-alpha gene expression in many cell lines. The form in which iron is presented to these cell lines appears to affect its availability for this function, and cells vary in their capabilities to use nontransferrin iron to support PKC-beta gene expression. Finally, transcriptional upregulation of PKC-beta by FeTF is mediated by DNA sequences located between -2200 bp and -587 bp in the 5'-flanking region of the human PKC-beta gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7949105

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Role of iron in Nramp1-mediated inhibition of mycobacterial growth.

Authors:  B S Zwilling; D E Kuhn; L Wikoff; D Brown; W Lafuse
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

2.  Dopamine D2 receptor expression is altered by changes in cellular iron levels in PC12 cells and rat brain tissue.

Authors:  Erica L Unger; Jason A Wiesinger; Lei Hao; John L Beard
Journal:  J Nutr       Date:  2008-12       Impact factor: 4.798

Review 3.  Desferoxamine (DFO)--mediated iron chelation: rationale for a novel approach to therapy for brain cancer.

Authors:  Pouya N Dayani; Maria C Bishop; Keith Black; Paul M Zeltzer
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

4.  Longitudinal study on thyroid function in patients with thalassemia major: High incidence of central hypothyroidism by 18 years.

Authors:  Ashraf T Soliman; Fawzia Al Yafei; Lolwa Al-Naimi; Noora Almarri; Aml Sabt; Mohamed Yassin; Vincenzo De Sanctis
Journal:  Indian J Endocrinol Metab       Date:  2013-11

5.  In Vivo Measurements of Tumor Metabolism and Growth after Administration of Enzastaurin Using Small Animal FDG Positron Emission Tomography.

Authors:  Karen E Pollok; Michael Lahn; Nathan Enas; Ann McNulty; Jeremy Graff; Shanbao Cai; Jennifer R Hartwell; Aaron Ernstberger; Donald Thornton; Les Brail; Gary Hutchins
Journal:  J Oncol       Date:  2009-05-27       Impact factor: 4.375

6.  Regulation of divalent metal transporter-1 by serine phosphorylation.

Authors:  Young Ah Seo; Ruvin Kumara; Herbert Wetli; Marianne Wessling-Resnick
Journal:  Biochem J       Date:  2016-09-28       Impact factor: 3.857

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.